Rappta Therapeutics
Series ARappta Therapeutics raised €9.0M in a Series A round in Oct 2020. The company is based in Helsinki, Finland. Investors in the round: Novartis Venture Fund, Novo Holdings. Data as of Nov 2026.
Amount raised
€9.0M
€9,000,000
Native amount
9,000,000 EUR
Stage
Series A
series a
Investors
2
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €9.0M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Oct 2020
Round type
series a
Amount (EUR)
€9.0M
Other rounds
same companyThis is the company's only recorded round.